Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: results from ms paths

被引：0
|
作者：
Hersh, C. [1 ]
Kieseier, B. [2 ]
De Moor, C. [2 ]
Miller, D. [3 ]
Campagnolo, D. [2 ]
Williams, J. [2 ]
Fitzgerald, K. [4 ]
Xiong, K. [2 ]
Mcginley, M. [3 ]
Hyland, M. [5 ]
Rudick, R. [2 ]
Ziemssen, T. [6 ,7 ]
Koulinska, I. [2 ]
机构：
[1] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Mellen Program MS, Las Vegas, NV USA
[2] Biogen, Cambridge, MA USA
[3] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[5] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14627 USA
[6] Univ Clin Carl Gustav Carus, Multiple Sclerosis Ctr, Dresden, Germany
[7] Univ Clin Carl Gustav Carus, Neuroimmunol Lab, Dresden, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1036
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [31] Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey
    Stenson, Katie
    Fecteau, T. E.
    O'Callaghan, L.
    Bryden, P.
    Mellor, J.
    Wright, J.
    Earl, L.
    Thomas, O.
    Iqbal, H.
    Barlow, S.
    Parvanta, S.
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2390 - 2404
  • [32] Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey
    Katie Stenson
    T. E. Fecteau
    L. O’Callaghan
    P. Bryden
    J. Mellor
    J. Wright
    L. Earl
    O. Thomas
    H. Iqbal
    S. Barlow
    S. Parvanta
    Journal of Neurology, 2024, 271 : 2390 - 2404
  • [33] The prevalence of bipolar disorders and impact on quality of life in a cohort of patients with multiple sclerosis
    Morales, I. Berrios
    Jun-O'Connell, A.
    Butala, A.
    Ahlawat, A.
    Henninger, N.
    Deligiannidis, K.
    Byatt, N.
    Ionete, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 224 - 225
  • [34] Clinical and imaging activity in a post-natalizumab real-world multiple sclerosis portuguese population
    Sequeira, M.
    Ferro, M.
    Barros, A.
    Sousa, A.
    Sequeira, J.
    Parra, J.
    Brum, M.
    Pedrosa, R.
    Capela, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 755 - 756
  • [35] The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
    De Masi, Roberto
    Orlando, Stefania
    De Donno, Antonella
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 12
  • [36] No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS
    Ryerson, Lana Zhovtis
    Naismith, Robert T.
    Krupp, Lauren B.
    Charvet, Leigh E.
    Liao, Shirley
    Fisher, Elizabeth
    de Moor, Carl
    Williams, James R.
    Campbell, Nolan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [37] Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study
    Itakura, Asako
    Tani, Yumiko
    Kaneko, Naoko
    Hide, Michihiro
    JOURNAL OF DERMATOLOGY, 2018, 45 (08): : 963 - 970
  • [38] INDIRECT SOCIAL COST OF MULTIPLE SCLEROSIS: RESULTS FROM A REAL-WORLD OBSERVATIONAL STUDY
    Kirzinger, S.
    Halper, J.
    Jeffery, D.
    Preblick, R.
    Bi, Y. J.
    Bharmal, M.
    Jo, H.
    VALUE IN HEALTH, 2009, 12 (07) : A233 - A234
  • [39] REAL-WORLD IMPACT OF TREATED HEREDITARY ANGIOEDEMA ATTACKS ON PATIENTS' QUALITY OF LIFE
    Busse, P.
    Craig, T. J.
    Radojicic, C.
    O'Connor, M.
    Christiansen, S.
    Ulloa, J.
    Danese, S.
    Andriotti, T.
    Audhya, P.
    Desai, V
    VALUE IN HEALTH, 2024, 27 (06) : S346 - S346
  • [40] Characteristics of multiple sclerosis patients treated with highly effective DMTs in a large real-world cohort
    Hersh, C.
    Honomichl, R.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 858 - 858
12345